Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Mindfulness and fear of hypoglycaemia in parents of children with Type 1 diabetes: results from Diabetes MILES Youth - The Netherlands.

Aalders J, Hartman E, Nefs G, Nieuwesteeg A, Hendrieckx C, Aanstoot HJ, Winterdijk P, van Mil E, Speight J, Pouwer F.

Diabet Med. 2018 May;35(5):650-657. doi: 10.1111/dme.13594. Epub 2018 Feb 27.

2.

Assessing Teratogenicity from the Clustering of Abnormal Phenotypes in Individual Zebrafish Larvae.

Aalders J, Ali S, de Jong TJ, Richardson MK.

Zebrafish. 2016 Dec;13(6):511-522. Epub 2016 Aug 25.

PMID:
27560445
3.

Comment on Schmitz et al. Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes care 2014;37:970-978.

Aalders J, Pouwer F.

Diabetes Care. 2014 Jun;37(6):e145. doi: 10.2337/dc14-0062. No abstract available.

PMID:
24855174
4.

Teratological effects of a panel of sixty water-soluble toxicants on zebrafish development.

Ali S, Aalders J, Richardson MK.

Zebrafish. 2014 Apr;11(2):129-41. doi: 10.1089/zeb.2013.0901. Epub 2014 Mar 20.

5.

Less gastrointestinal toxicity after adjuvant radiotherapy on a small pelvic field compared to a standard pelvic field in patients with endometrial carcinoma.

de Jong RA, Pras E, Boezen HM, van der Zee AG, Mourits MJ, Arts HJ, Aalders JG, Slot A, Timmer PR, Hollema H, Nijman HW.

Int J Gynecol Cancer. 2012 Sep;22(7):1177-86. doi: 10.1097/IGC.0b013e31826302dd.

PMID:
22854651
6.

Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes.

Aalders JG, Thomas G.

Gynecol Oncol. 2007 Jan;104(1):222-31. Epub 2006 Nov 28. Review.

PMID:
17126892
7.

Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery.

Nijhuis ER, van der Zee AG, in 't Hout BA, Boomgaard JJ, de Hullu JA, Pras E, Hollema H, Aalders JG, Nijman HW, Willemse PH, Mourits MJ.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):699-705. Epub 2006 Aug 14.

PMID:
16904839
8.

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.

Engelen MJ, Kos HE, Willemse PH, Aalders JG, de Vries EG, Schaapveld M, Otter R, van der Zee AG.

Cancer. 2006 Feb 1;106(3):589-98.

9.

Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.

Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG.

J Clin Oncol. 2005 Mar 1;23(7):1455-62.

PMID:
15735121
10.

Lymphvascular space involvement: an independent prognostic factor in endometrial cancer.

Briët JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, ten Hoor KA, Pras E, Boezen HM, van der Zee AG, Nijman HW.

Gynecol Oncol. 2005 Mar;96(3):799-804.

PMID:
15721428
11.

Vulvar carcinoma. The price of less radical surgery.

De Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, Aalders JG, Mourits MJ, Van Der Zee AG.

Cancer. 2002 Dec 1;95(11):2331-8.

12.

Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer.

Hofstra LS, Bos AM, de Vries EG, van der Zee AG, Willemsen AT, Rosing H, Beijnen JH, Mulder NH, Aalders JG, Willemse PH.

Gynecol Oncol. 2002 Jun;85(3):517-23.

PMID:
12051884
13.

Vulvar melanoma: is there a role for sentinel lymph node biopsy?

de Hullu JA, Hollema H, Hoekstra HJ, Piers DA, Mourits MJ, Aalders JG, van der Zee AG.

Cancer. 2002 Jan 15;94(2):486-91.

14.

Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment.

Pras E, Willemse PH, Canrinus AA, de Bruijn HW, Sluiter WJ, ten Hoor KA, Aalders JG, Szabo BG, de Vries EG.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):23-32.

PMID:
11777619
15.

A phase I and pharmacokinetic study of intraperitoneal topotecan.

Hofstra LS, Bos AM, de Vries EG, van der Zee AG, Beijnen JH, Rosing H, Mulder NH, Aalders JG, Willemse PH.

Br J Cancer. 2001 Nov 30;85(11):1627-33.

16.

Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.

Esajas MD, Duk JM, de Bruijn HW, Aalders JG, Willemse PH, Sluiter W, Pras B, ten Hoor K, Hollema H, van der Zee AG.

J Clin Oncol. 2001 Oct 1;19(19):3960-6.

PMID:
11579117
17.

Sentinel lymph node detection in locally recurrent carcinoma of the vulva.

de Hullu JA, Piers DA, Hollema H, Aalders JG, van der Zee AG.

BJOG. 2001 Jul;108(7):766-8. No abstract available.

18.

Noninvasive detection of inguinofemoral lymph node metastases in squamous cell cancer of the vulva by L-

De Hullu JA, Pruim J, Qué TH, Aalders JG, Boonstra H, Vaalburg W, Hollema H, Van Der Zee AG.

Int J Gynecol Cancer. 1999 Mar;9(2):141-146.

PMID:
11240756
19.

Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva.

de Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, Aalders JG, van Der Zee AG.

J Clin Oncol. 2000 Aug;18(15):2811-6.

PMID:
10920128
20.

Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.

Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG.

Gynecol Oncol. 2000 Jul;78(1):16-20.

PMID:
10873403
21.

The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.

de Bruijn HW, Duk JM, van der Zee AG, Pras E, Willemse PH, Boonstra H, Hollema H, Mourits MJ, de Vries EG, Aalders JG.

Tumour Biol. 1998;19(6):505-16.

PMID:
9817980
22.

Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva.

de Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Koops HS, Boonstra H, van der Zee AG.

J Nucl Med. 1998 Aug;39(8):1381-5.

23.

The value of cancer antigen 125 (CA 125) during treatment and follow-up of patients with ovarian cancer.

de Bruijn HW, van der Zee AG, Aalders JG.

Curr Opin Obstet Gynecol. 1997 Feb;9(1):8-13. Review.

PMID:
9090475
24.

Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervix.

Pras E, Willemse PH, Boonstra H, Hollema H, Heesters MA, Szabó BG, de Bruijn HW, Aalders JG, de Vries EG.

Ann Oncol. 1996 Jul;7(5):511-6.

PMID:
8839907
25.

[Ovarian carcinoma in the elderly; a diagnostic and therapeutic dilemma].

Wymenga AN, Willemse PH, Aalders JG, Sleijfer DT.

Ned Tijdschr Geneeskd. 1996 Mar 23;140(12):650-3. Review. Dutch. No abstract available.

PMID:
8668237
26.

Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.

Duk JM, Groenier KH, de Bruijn HW, Hollema H, ten Hoor KA, van der Zee AG, Aalders JG.

J Clin Oncol. 1996 Jan;14(1):111-8.

PMID:
8558185
27.

Cell biological markers of drug resistance in ovarian carcinoma.

van der Zee AG, Hollema HH, de Bruijn HW, Willemse PH, Boonstra H, Mulder NH, Aalders JG, de Vries EG.

Gynecol Oncol. 1995 Aug;58(2):165-78. Review.

PMID:
7622101
28.

Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trial.

Veldhuis GJ, Willemse PH, van Gameren MM, Aalders JG, Mulder NH, Mull B, Biesma B, de Vries EG.

J Clin Oncol. 1995 Mar;13(3):733-40.

PMID:
7884433
29.

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.

van der Zee AG, Hollema H, Suurmeijer AJ, Krans M, Sluiter WJ, Willemse PH, Aalders JG, de Vries EG.

J Clin Oncol. 1995 Jan;13(1):70-8.

PMID:
7799045
30.

Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma.

Veenhof CH, van der Burg ME, Nooy M, Aalders JG, Pecorelli S, Oliveira CF, Rotmensz N, Vermorken JB.

Eur J Cancer. 1994;30A(5):697-8.

PMID:
8080689
31.

Total pelvic exenteration: a justified procedure.

Plukker JT, Aalders JG, Mensink HJ, Oldhoff J.

Br J Surg. 1993 Dec;80(12):1615-7.

PMID:
8298942
32.

Aspects of surgery in ovarian and endometrial carcinoma.

Aalders JG, Neijt JP.

Eur J Cancer. 1993;29A(4):624-8. Review.

PMID:
8435220
33.
34.

Carboplatin with cyclophosphamide in patients with advanced ovarian cancer: an efficacy and quality-adjusted survival analysis.

Willemse PH, De Vries EG, Kloppenburg M, Fontein DL, Aalders JG, Boonstra H, Mulder NH, Sleijfer DT.

Int J Gynecol Cancer. 1992 Sep;2(5):236-243.

PMID:
11576264
35.

Symptomatology, localization and treatment of recurrent cervical carcinoma.

Tinga DJ, Bouma J, Boonstra H, Aalders JG.

Int J Gynecol Cancer. 1992 Jul;2(4):179-188.

PMID:
11576257
36.

Patients with squamous cell versus adeno(squamous) carcinoma of the cervix, what factors determine the prognosis?

Tinga DJ, Bouma J, Aalders JG.

Int J Gynecol Cancer. 1992 Mar;2(2):83-91.

PMID:
11576241
37.

Confocal microscopy in microgravity research.

Goede AP, Brakenhoff GJ, Woldringh CL, Aalders JW, Imhof JP, van Kralingen P, Mels WA, Schreinemakers P, Zegers A.

Adv Space Res. 1992;12(1):109-12.

PMID:
11536944
38.

[The hematopoietic growth factor GM-CSF in chemotherapy for ovarian carcinoma].

Biesma B, Willemse PH, Vellenga E, Limburg PC, Aalders JG, de Vries EG.

Ned Tijdschr Geneeskd. 1991 Mar 9;135(10):420-4. Dutch.

PMID:
2020314
39.
40.

Endodermal sinus tumor of the ovary during pregnancy: a case report.

van der Zee AG, de Bruijn HW, Bouma J, Aalders JG, Oosterhuis JW, de Vries EG.

Am J Obstet Gynecol. 1991 Feb;164(2):504-6.

PMID:
1704183
41.

Palmar fasciitis and arthritis in a patient with an extraovarian adenocarcinoma of the coelomic epithelium.

Willemse PH, Mulder NH, van de Tempel HJ, Aalders JG, Sleijfer DT.

Ann Rheum Dis. 1991 Jan;50(1):53-4.

42.

A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma.

de Vries EG, Biesma B, Willemse PH, Mulder NH, Stern AC, Aalders JG, Vellenga E.

Cancer Res. 1991 Jan 1;51(1):116-22.

43.

CA-125 in ovarian cancer: relation between half-life, doubling time and survival.

Willemse PH, Aalders JG, de Bruyn HW, Mulder NH, Sleijfer DT, de Vries EG.

Eur J Cancer. 1991;27(8):993-5.

PMID:
1832911
44.

Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations.

Duk JM, de Bruijn HW, Groenier KH, Hollema H, ten Hoor KA, Krans M, Aalders JG.

Gynecol Oncol. 1990 Nov;39(2):186-94.

PMID:
2227594
45.

Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB.

Tinga DJ, Timmer PR, Bouma J, Aalders JG.

Gynecol Oncol. 1990 Nov;39(2):175-80.

PMID:
2227592
46.

Detection, prevalence, and prognosis of asymptomatic carcinoma of the cervix.

Tinga DJ, Beentjes JA, Van de Wiel HB, Boonstra H, Bouma J, Aalders JG.

Obstet Gynecol. 1990 Nov;76(5 Pt 1):860-4.

PMID:
2216238
47.

The effect of abdominal surgery on the serum concentration of the tumour-associated antigen CA 125.

van der Zee AG, Duk JM, Aalders JG, Boontje AH, ten Hoor KA, de Bruijn HW.

Br J Obstet Gynaecol. 1990 Oct;97(10):934-8.

PMID:
2223686
49.

Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer.

Willemse PH, de Vries EG, Mulder NH, Aalders JG, Bouma J, Sleijfer DT.

Eur J Cancer. 1990 Mar;26(3):353-8.

PMID:
2141493
50.

Risks and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysis.

Willemse PH, van Lith J, Mulder NH, Aalders JG, Bouma J, de Vries EG, Sleijfer DT.

Eur J Cancer. 1990 Mar;26(3):345-52.

PMID:
2141492

Supplemental Content

Loading ...
Support Center